leisure time -WSS

leisure time

author：comprehensive 2025-09-30 16:15:04 - browse：464

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Congressmen charge Covid hearing ‘could have been an email’

WSS

STAT Readout Newsletter: Today's biggest biotech updates

SAMSHA loosens regulations on methadone treatment centers

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

What we need to know about Arena Bioworks

Cognito secures funding to test medical device for Alzheimer's

STAT Summit: Michael J. Fox on progress in Parkinson's research

hotspot

leisure time

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Even great ERs can’t make up for American health disparities

Jerome Adams on the need for new antivirals for Covid

Novo Nordisk to expand supply of Wegovy for U.S. patients

Medicare details structure of new drug price negotiation program

STAT Readout Newsletter: Today's biggest biotech updates

In Memoriam: Notable people who died in 2023

Pharmacists can make shortage drugs, but at what cost?

Cancer drug shortages should be causing more outrage

Commercial surrogacy can be ethical, despite pope’s claims

knowledge

The EU Joint Clinical Assessment needs to live up to its promise

ARCH Venture Partners is raising $3 billion for a life sciences fund

The EU Joint Clinical Assessment needs to live up to its promise

Studies point to risks of excluding people with obesity from drug trials

Why health workers in Gaza are injured or die at high rates

STAT Summit: Biotech founders on deal

hotspot

leisure time

Wikipedia

Wikipedia